Time to re-evaluate combination antifungal therapy for invasive aspergillosis and other invasive mycoses

Key Points

• Combination antifungal therapy may enhance outcomes in patients with invasive mycoses.
• Current guidelines do not fully address treatment efficacy for invasive aspergillosis and other fungal infections.
• This analysis focuses on various fungal pathogens and their responses to existing therapies.
• Re-evaluation is needed to improve clinical outcomes based on updated data and observations.